CRISPR/Cas9 technology generated a TGT to GCT change at the redox-regulated residue C254 resulting in a cysteine to alanine substitution at this residue (C254A). This substitution is thought to destabilize the inactive conformation and desensitize UCP1 to activation. (J:321712)